paclitaxel-carboplatin-bevacizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for paclitaxel-carboplatin-bevacizumab, covering 2020-09-28 to 2020-09-28. Get the full timeline:
Most recent: Clinical Trial Update: Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer [Phase 2]